Skip to main content
Premium Trial:

Request an Annual Quote

Labcorp Receives FDA EUA for Combo COVID-19/Flu Home Collection Kit

NEW YORK – Laboratory Corporation of America said on Friday that it has received Emergency Use Authorization from the US Food and Drug Administration for a combined home collection kit for molecular testing for COVID-19 and influenza A/B.

The kit is intended for use in individuals 2 years of age and older and is available at no upfront cost to those who meet clinical guidelines, which include individuals experiencing symptoms, those who have been exposed to someone with COVID-19, or those who have been recommended for testing by a healthcare provider.

The collection kit uses the Roche Cobas SARS-CoV-2 & Influenza A/B Test for use on the Cobas 6800/8800 Systems for testing nasal or nasopharyngeal samples. The Cobas SARS-CoV-2 & Influenza A/B Test is an RT-PCR assay that simultaneously and qualitatively detects and differentiates the SARS-CoV-2, influenza A, and influenza B viruses.

The kit will become available in early October and can be ordered either through Pixel by Labcorp or by an individual's physician.

"Our newest home collection kit makes it convenient for individuals, including children over the age of 2, to take the test in the safety of their homes," Brian Caveney, chief medical officer and president of Labcorp Diagnostics, said in a statement. "In time for flu season, the single test helps doctors and individuals make more informed treatment decisions given that symptoms of COVID-19 and flu are similar."

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.